Listing 1 - 2 of 2 |
Sort by
|
Choose an application
In a world where there is increasing demand for the performance of health providers to be measured, there is a need for a more strategic vision of the role that performance measurement can play in securing health system improvement. This volume meets this need by presenting the opportunities and challenges associated with performance measurement in a framework that is clear and easy to understand. It examines the various levels at which health system performance is undertaken, the technical instruments and tools available, and the implications using these may have for those charged with the governance of the health system. Technical material is presented in an accessible way and is illustrated with examples from all over the world. Performance Measurement for Health System Improvement is an authoritative and practical guide for policy makers, regulators, patient groups and researchers.
W 84 Health services. Quality of health care (General) --- Health System Plans --- Health Care Quality, Access, and Evaluation --- Outcome Assessment (Health Care) --- Process Assessment (Health Care) --- Delivery of Health Care --- Organisation and Administration --- health economics --- Hygiene. Public health. Protection --- Medical care --- Public health --- Evaluation. --- Business, Economy and Management --- Economics --- Health program evaluation --- santé --- infrastructure sanitaire et sociale --- hopital --- centre de soins --- cout de la santé
Choose an application
Despite the pharmaceutical industry's notable contributions to human progress, including the development of miracle drugs for treating cancer, AIDS, and heart disease, there is a growing tension between the industry and the public. Government officials and social critics have questioned whether the multibillion-dollar industry is fulfilling its social responsibilities. This doubt has been fueled by the national debate over drug pricing and affordable healthcare, and internationally by the battles against epidemic diseases, such as AIDS, in the developing world. Debates are raging over how the industry can and should be expected to act. The contributions in this book by leading figures in industry, government, NGOs, the medical community, and academia discuss and propose solutions to the ethical dilemmas of drug industry behavior. They examine such aspects as the role of intellectual property rights and patent protection, the moral and economic requisites of research and clinical trials, drug pricing, and marketing.
Drugs --- Medical innovations --- Pharmaceutical industry. --- Social responsibility of business. --- Marketing --- Moral and ethical aspects. --- Research --- Social aspects. --- HD 9665.5 Pharmaceutical Industry --- pharmacie --- prijsvorming --- Ethics, Medical --- Pharmaceutical Preparations --- Drug Industry --- Varia organisaties en instellingen (GV) : Farmaceutische firma's --- Diverses organisations et institutions (SS) : Firmes pharmaceutiques --- Business --- Corporate accountability --- Corporate responsibility --- Corporate social responsibility --- Corporations --- CSR (Corporate social responsibility) --- Industries --- Social responsibility, Corporate --- Social responsibility of industry --- Business ethics --- Issues management --- Society and medical innovations --- Medicaments --- Medications --- Medicine (Drugs) --- Medicines (Drugs) --- Pharmaceuticals --- Prescription drugs --- Bioactive compounds --- Medical supplies --- Pharmacopoeias --- Chemotherapy --- Materia medica --- Pharmacology --- Pharmacy --- Drug industry --- Drug trade --- Medicine industry --- Medicines industry --- Prescription medicine industry --- Chemical industry --- Social responsibility --- Social aspects --- Business, Economy and Management --- Business Management --- Droit médical
Listing 1 - 2 of 2 |
Sort by
|